Daniel Shaham

Daniel Shaham

Auto-generated profile, based on publicly available information

Daniel Shaham

IBD Unit, Department of Gastroenterology and Liver Diseases, Tel Aviv Sourasky Medical Center, Israel; Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2025 in Digestive Diseases
Verified
Journal Article
Open access
YMYuval Meir
Yuval Meir
HLHaim Leibovitzh
Haim Leibovitzh
DSDaniel Shaham
Daniel Shaham
AHAyal Hirsch
Ayal Hirsch
NCNathaniel Aviv Cohen
Nathaniel Aviv Cohen
Nitsan MaharshakNitsan Maharshak
Nitsan Maharshak
Introduction: The management of Crohn’s disease (CD) in older-adult patients is challenging due to age-related immune decline, comorbidities, and the excessive risk of adverse effects from pharmacological treatments. The Crohn’s Disease Exclusion Diet (CDED) has shown promise in treating younger populations, but its effectiveness in older-adults remains understudied. This study aimed to evaluate the CDED effectiveness in older-adults with CD. Methods: A single-center retrospective cohort study, including patients over 60 years old with CD who initiated CDED between 2018 and 2024. Patients were categorized based on baseline disease clinical activity using the Harvey Bradshaw Index (HBI). Clinical and biochemical outcomes (fecal calprotectin [FCAL] and C-reactive protein) were assessed over a 24-week follow-up. Results: The study included 40 patients, 70% females, mean age of 69.2 ± 7.6 years, and mean Charlson Comorbidity Index score of 3.37 ± 1.4. Most of the patients (85%) initiated the CDED in phase 1. At baseline, 60% were in clinical remission and 40% had active disease. Patients with active disease demonstrated a significant clinical (HBI) improvement at week 6 which was sustained throughout week 12 (p < 0.05), while patients in remission maintained stable HBI. A Significant decrease in FCAL was observed at week 12 (p = 0.02). Conclusion: The CDED appears to be an effective dietary intervention for managing CD in older-adults, offering potential benefits both in treating active disease and maintaining clinical remission. This diet could serve as an alternative or adjunct approach to pharmacological therapies, particularly for patients with mild disease or those at risk of adverse effects from advanced treatments.

5 June 2025 in The American Journal of Surgery
Verified
Journal Article
Open access
DSDaniel Shaham
Daniel Shaham
SNShira Naveh
Shira Naveh
MZMeir Zemel
Meir Zemel
YKYehuda Kariv
Yehuda Kariv
HLHaim Leibovitzh
Haim Leibovitzh
Jonathan Benjamin YuvalJonathan Benjamin Yuval
Jonathan Benjamin Yuval
Smoking is associated with increased severity and recurrence of Crohn's disease (CD), but its impact on perioperative outcomes is unclear. This study evaluated the association between smoking and 90-day postoperative complications in patients with CD undergoing abdominal surgery. We conducted a retrospective cohort study (2017-2019) of 294 patients with CD who underwent abdominal surgery. Patients were categorized as current smokers versus past/never smokers. Outcomes included 90-day complications, severe complications (Clavien-Dindo ≥3), and length of stay (LOS). Multivariable regression was performed to adjust for confounders. Current smokers (n ​= ​79, 26.8 ​%) had higher rates of overall (64.6 ​% vs. 43.7 ​%, p ​= ​0.002) and severe complications (19 ​% vs. 6.5 ​%, p ​= ​0.001). Smoking was independently associated with overall complications (OR ​= ​2.17), severe complications (OR ​= ​3.20), and prolonged LOS (β ​= ​3.01 days, p ​= ​0.002). Past smokers had outcomes similar to never smokers. Current smoking is independently associated with increased complications and longer hospitalization following CD surgery.

22 May 2025 in Journal of Shoulder and Elbow Surgery
Verified
Journal Article
Open access
DSDaniel Shaham
Daniel Shaham
BHBarak Haviv
Barak Haviv
MKMohamed Kittani
Mohamed Kittani
MYMustafa Yassin
Mustafa Yassin
TYTzadok Yona
Tzadok Yona
LYLee Yaari
Lee Yaari
Proximal humerus fractures (PHFs) are the third most common type of osteoporotic fracture. One-year mortality rates following PHF are between 4% and 15%. This study examines whether combined fractures involving PHFs and other osteoporotic fractures increase mortality and morbidity rates compared with isolated PHFs. This is a retrospective study on patients aged ≥45 years with PHF between January 1, 2011, and December 31, 2020, in Israel's largest health maintenance organization. Fractures were categorized as isolated PHFs or combined fractures involving the proximal humerus with a femoral, distal radial, or vertebral fracture. Patient characteristics, mortality, and morbidity were recorded. Kaplan-Meier survival curves and Cox regression models were used to assess mortality and morbidity. This study included 21,647 patients, 713 in the combined fracture group and 20,934 in the isolated PHF group. The combined fracture group had significantly higher 1-year mortality (14.7% vs. 5.7%, P < .001). After adjusting for covariates, combined fractures involving the femur (hazard ratio [HR] = 1.885, P = .003) or vertebra (HR = 1.751, P = .020) were associated with higher mortality, whereas combined fractures with the radius were not. Morbidity was higher in the combined fracture group, with increased rates of pulmonary embolism (HR = 2.740, P = .012), deep vein thrombosis (HR = 4.982, P = .021), and sepsis (HR = 2.132, P = .018). This study showed that combined fractures with femoral or vertebral fractures are associated with significantly higher mortality and morbidity compared with isolated PHFs.

26 June 2026 in The American Journal of Surgery
Verified
Journal Article
Open access
DSDaniel Shaham
Daniel Shaham
SNShira Naveh
Shira Naveh
MZMeir Zemel
Meir Zemel
YKYehuda Kariv
Yehuda Kariv
HLHaim Leibovitzh
Haim Leibovitzh
Jonathan Benjamin YuvalJonathan Benjamin Yuval
Jonathan Benjamin Yuval
To evaluate the impact of high and low Body mass index (BMI) on 90-day postoperative outcomes in patients with Crohn's disease (CD). This retrospective cohort study (2017-2019) included 271 patients undergoing abdominal surgery, categorized as underweight (BMI 30). Primary outcomes were 90-day overall and severe (Clavien-Dindo >2) complications and total length of stay (LOS). The cohort comprised 64 underweight, 189 normal/overweight, and 18 obese patients. Multivariable analysis revealed that underweight status was independently associated with higher overall complications (OR = 2.0, p = 0.045), severe complications (OR = 3.05, p = 0.018), and increased total LOS (beta = 3.43, p = 0.003). While obesity showed a trend toward higher morbidity in univariable analysis, it did not maintain independent significance after adjustment (p = 0.159). Underweight status is a significant independent predictor of poor 90-day postoperative outcomes in patients with CD, necessitating targeted preoperative nutritional optimization.